key: cord-1040348-tbxjodu0 authors: Maniakas, Anastasios; Jozaghi, Yelda; Zafereo, Mark E.; Sturgis, Erich M.; Su, Shirley Y.; Gillenwater, Ann M.; Gidley, Paul W.; Lewis, Carol M.; Diaz, Eduardo; Goepfert, Ryan P.; Kupferman, Michael E.; Gross, Neil D.; Hessel, Amy C.; Pytynia, Kristen B.; Nader, Marc‐Elie; Wang, Jennifer R.; Lango, Miriam N.; Kiong, Kimberley L.; Guo, Theresa; Zhao, Xiao; Yao, Christopher M. K. L.; Appelbaum, Eric; Alpard, Jennifer; Garcia, Jose A.; Terry, Shawn; Flynn, Jill E.; Bauer, Sarah; Fournier, Danielle; Burgess, Courtlyn G.; Wideman, Cayla; Johnston, Matthew; You, Chenxi; De Luna, Rolando; Joseph, Liza; Diersing, Julia; Prescott, Kaitlin; Heiberger, Katherine; Mugartegui, Lilian; Rodriguez, Jessica; Zendehdel, Sara; Sellers, Justin; Friddell, Rebekah A.; Thomas, Ajay; Khanjae, Sonam J.; Schwarzlose, Katherine B.; Chambers, Mark S.; Hofstede, Theresa M.; Cardoso, Richard C.; Wesson, Ruth Aponte; Won, Alex; Otun, Adegbenga O.; Gombos, Dan S.; Al‐Zubidi, Nagham; Hutcheson, Katherine A.; Gunn, G. Brandon; Rosenthal, David I.; Gillison, Maura L.; Ferrarotto, Renata; Weber, Randal S.; Hanna, Ehab Y.; Myers, Jeffrey N.; Lai, Stephen Y. title: Head and neck surgical oncology in the time of a pandemic: Subsite‐specific triage guidelines during the COVID‐19 pandemic date: 2020-05-27 journal: Head Neck DOI: 10.1002/hed.26206 sha: adc4b7a07c356fcb23f850d39898b42f5d3b8799 doc_id: 1040348 cord_uid: tbxjodu0 BACKGROUND: COVID‐19 pandemic has strained human and material resources around the world. Practices in surgical oncology had to change in response to these resource limitations, triaging based on acuity, expected oncologic outcomes, availability of supportive resources, and safety of health care personnel. METHODS: The MD Anderson Head and Neck Surgery Treatment Guidelines Consortium devised the following to provide guidance on triaging head and neck cancer (HNC) surgeries based on multidisciplinary consensus. HNC subsites considered included aerodigestive tract mucosa, sinonasal, salivary, endocrine, cutaneous, and ocular. RECOMMENDATIONS: Each subsite is presented separately with disease‐specific recommendations. Options for alternative treatment modalities are provided if surgical treatment needs to be deferred. CONCLUSION: These guidelines are intended to help clinicians caring for patients with HNC appropriately allocate resources during a health care crisis, such as the COVID‐19 pandemic. We continue to advocate for individual consideration of cases in a multidisciplinary fashion based on individual patient circumstances and resource availability. The novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) causing coronavirus disease 2019 (COVID-19) emerged in December 2019 and has spread on a global level leading to unprecedented health, social, and economical unrest. The virus is spread via respiratory droplets and causes mortality in up to 7% of infected patients. 1 Curative treatment and vaccines are nonexistent, and the only protection is the prevention of spread of virus particles. Many asymptomatic patients might be carriers of disease, while current testing paradigms might have false negative rates as high as 40%. 2 As such, all patients and health care providers are considered a potential source of disease. On March 11, 2020 , the World Health Organization declared the SARS-CoV-2 outbreak a pandemic, 3 at a time when the Center for Disease Control reported 1215 positive cases in the United States. 4 At the time of this report, the United States has reached 395 011 cases. 4 At the current rate of disease progression, intensive care unit (ICU) beds are projected to be at or over capacity with COVID-19 patients across the country. Health institutions in several states have implemented mandatory postponement of elective and/or nonurgent cases to decrease nonessential patient density in hopes of decreasing COVID-19 transmission and preserving hospital resources. As the current pandemic is rapidly evolving, the American College of Surgeons has recommended triaging surgeries according to a three-tier state of hospital resource availibility. 5 In the field of head and neck surgical oncology, postponing a surgery can significantly impact survival due to the increased risk of cancer progression. Furthermore, early reports suggest that patients with cancer are at higher risk for COVID-19 associated severe events such as ICU admissions requiring mechanical ventilation or death. 6, 7 Given the cancer patients' vulnerability to COVID-19 complications and potential hospital resource limitations, judicious selection of oncologic surgical cases is of utmost importance, not only in an attempt to alleviate the burden on the health care system, but also to ensure the safety of patients, their families, as well as their health care providers. Ultimately, one must balance health care priorities and the risk of cancer progression. In this report, we outline guidelines based on expert consensus opinions from our experienced multidisciplinary team for the triage and prioritization of head and neck surgical cases in a subsite-specific manner. We present these guidelines to serve as a reference for practicing head and neck clinicians during this serious and unprecedented situation, recognizing that feasibility, pandemic intensity, and resource availability will vary widely geographically and over time. The MD Anderson Head and Neck Surgery Consortium incorporates faculty and advanced practice providers from the five subsections of the Department of Head and Neck Surgery at the University of Texas MD Anderson Cancer Center: Head and Neck Surgical Oncology, Head and Neck Endocrine Surgery, Oral Oncology and Maxillofacial Prosthodontics, Ophthalmology, and Speech Pathology and Audiology. In a collaborative effort, the following guidelines were prepared to provide clinicians subsite-specific guidance for triaging surgical case acuity. Expertise was sought from our Radiation Oncology and Medical Oncology colleagues for nonsurgical treatment options when surgery could be reasonably deferred, and for patients requiring multimodality therapy. These guidelines are intended to serve as a direction in a time of crisis such as the COVID-19 pandemic and not as a strategy for permanent change in patterns of practice. Our weekly Multidisciplinary Planning Conference is currently conducted over a web conferencing platform in accordance with institutional and national social distancing recommendations. When a case is selected for surgery, a case posting request is placed and sent to the Division of Surgery Surgical Posting Committee for daily institutional review. This committee is comprised of surgical department chairs and quality officers, the Operating Room Committee leadership, and anesthesiologists. In Head and Neck Surgery, the guidelines described below are currently being used to assess treatment decisions and to make recommendations to the Division of Surgery Surgical Posting Committee. Approved cases are forwarded to the surgical scheduling team. An institutional bioethicist is available as needed. The following guidelines based on current expert clinical opinion are provided for management of patients with head and neck cancer (HNC) during the COVID-19 pandemic given the potential limited resources available. Given the acute nature of this clinical dilemma, there is not sufficient time to perform clinical trials for level-one evidence. Our guidelines emphasize surgical treatment of intermediate and advanced disease where nonsurgical options are not available, and risk of disease progression would significantly affect patient function or disease outcome. • Ideally, where testing is readily and rapidly available, SARS-CoV-2 testing should be performed on all patients with mucosal lesions prior to HNS evaluation, and/or, at the least, 1 day prior to the planned surgery. • Selected patients may be closely observed allowing for deferral/rescheduling of surgery. • Significant functional loss or life-threatening disease requires immediate attention. • Telemedicine is an essential tool in several medical fields during these times and has been recommended to be used when deemed appropriate by the American Academy of Otolaryngology-Head and Neck Surgery. 8 • At our institution, as a general guideline for scheduling, cases are deferred when performed for prophylactic intent, benign diseases, conditions unlikely to be adversely affected by an 8 to 12-week surgical delay, or for conditions which have available and appropriate alternative therapies. • In-depth discussion and review is performed when patients have a severely depressed performance status, high comorbidity burden and/or advanced age, or when surgical cases may require significant blood transfusion (>4 units), ICU care, or a prolonged hospitalization is anticipated. • Although multimodality input is sought after preoperatively for patients requiring multimodality therapy, we suggest deferring all head and neck radiation and medical oncology consultations to when needed to minimize exposure risks, unless neoadjuvant treatment is considered. • Flexible naso-pharyngo-laryngoscopies are limited to when medically necessary. When performed, they are recorded by the health care provider for shared review to eliminate duplicate exposure risk. No resection until viral resolution unless significant functional threat or life-threatening situation as patients testing positive are associated with a high rate of mortality in the postoperative period. 9 • Powered air-purifying respirator (PAPR) equipment required for all involved in the case. • Minimize nonessential personnel in the operating room (trainees, advanced practice providers, visitors, etc). Patient must pass symptom screening and appropriate testing completed 1 day prior to intended surgery date. Begin with baseline airway evaluation to rule out risk of aspiration and/or the likelihood of becoming "at risk" for airway obstruction. 12 Nutritional status should also be evaluated, such as the patient's ability to feed by mouth vs being nasogastric/PEG-dependent. • • Suspected parathyroid carcinoma with significant symptomatic hypercalcemia. Grave's disease. The mastoid and middle ear mucosa may carry the same risk of viral aerosolization as sinus and nasal surgery due to the connection with the nasopharynx through the Eustachian tube. At a minimum, N95 mask is required for mastoid surgery. PAPR is required for the surgeon and OR staff in patients with SARS-CoV-2 positive status, and this equipment can interfere with the use of an operative microscope. Using an exoscope is an alternative, but this equipment might not be widely available. • The Institute of Medicine has established the goals of quality-based health care: safe, effective, patient-centered, timely, efficient, and equitable for all patients. 20 In our head and neck program, we strive to provide patients with highly coordinated and efficient care. However, the current pandemic has significantly impacted our ability to meet these goals for care delivery. An urgent effort was needed to mitigate the impact of the pandemic on patient care requiring an assessment of our available resources in the context of this widespread communicable disease. Using these guidelines has led to a significant shift in the management of patients with HNC at our institution. 21 Advanced oral cavity lesions requiring a mandibulectomy and/or maxillectomy currently represent the majority of head and neck surgical cases. More in depth analyses on the overall effect of the COVID-19 pandemic on surgical volume, case deferral, and use of alternative therapeutic options are being described in the literature 21, 22 and are beyond the scope and purpose of this current report. These recommendations are intended to provide a concise set of guidelines for the practicing head and neck clinician during a health care crisis, such as the COVID-19 pandemic, and may serve as a foundation to be modified in the event of future pandemics. Furthermore, these guidelines should be used in the context of individual institutional priorities, health care personnel safety, pandemic intensity, and availability of resources. Lastly, we continue to advocate for consideration of individual cases in a multidisciplinary fashion based on patient circumstances, and risk of disease progression. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy Detection of SARS-CoV-2 in different types of clinical specimens World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19: 11 Cumulative total number of COVID-19 cases in the United States by report date COVID-19: guidance for triage of non-emergent surgical procedures Risk of COVID-19 for patients with cancer Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China Prioritizing novel approaches to telehealth for all practitioners Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection Head and neck virtual medicine in a pandemic era: lessons from COVID-19. Authorea A framework for prioritizing head and neck surgery during the COVID-19 pandemic Management of the difficult airway in the COVID-19 pandemic: an illustrative complex head and neck case scenario Precautions for endoscopic transnasal skull base surgeryduring the covid-19 pandemic Short-term recommendations for cutaneous melanoma management during COVID-19 pandemic clinical practice guidelines in oncology -cutaneous melanoma version 1 Endocrine surgery in the coronavirus disease Considerations for the management and triage of ocular oncology cases during the COVID-19 pandemic List of urgent and emergent ophthalmic procedures Society of Retina Specialists (ASRS) member alert regarding the COVID-19 pandemic Institute of Medicine (US) Committee on quality of health care in America. Crossing the quality chasm: a new health system for the 21st century Changing practice patterns in Head & Neck Oncologic Surgery in the early COVID era Safety recommendations for evaluation and surgery of the head and neck during the COVID-19 pandemic. JAMA Otolaryngol Head Neck Surg. 2020. How to cite this article The authors declare no potential conflict of interest.